99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study
Crossref DOI link: https://doi.org/10.1186/s13550-016-0245-0
Published Online: 2016-12-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lambert, Bieke http://orcid.org/0000-0002-5674-0222
Carron, Philippe
D’Asseler, Yves
Bacher, Klaus
Van den Bosch, Filip
Elewaut, Dirk
Verbruggen, Gust
Beyaert, Rudi
Dumolyn, Caroline
De Vos, Filip
License valid from 2016-12-01